Tokyo, Dec. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059745) titled 'Prevalence and Incidence in patients with fibrosing ILD in Japan - A National Database Study' on Dec. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Nippon Boehringer Ingelheim Co., Ltd
Condition:
Condition - IPF, PPF, and non-progressive ILD
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the prevalence (per 100,000 people) and incidence (per 100,000 person-years) of IPF, PPF, and non-progressive ILD by calendar year in Japan.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gende...